Merck & Co. Inc. buy Royal Bank of Canada
Start price
30.03.26
/
50%
€102.80
Target price
30.03.27
€123.30
Performance (%)
-7.77%
Price
10:56
€94.81
Summary
This prediction is currently active. With a performance of -7.77%, the BUY prediction for Merck & Co. Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Merck & Co. Inc. | -5.663% |
| iShares Core DAX® | -1.741% |
| iShares Nasdaq 100 | 2.815% |
| iShares Nikkei 225® | -0.109% |
| iShares S&P 500 | 0.966% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat